Jashwanth raj J

Mr. Jashwanth raj J

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2025 in Chemistry
Verified
Journal Article
Open access
PDF file
SUSaranya Udayakumar
Saranya Udayakumar
SPShangavy Pandiarajan
Shangavy Pandiarajan
DMDevadass Jessy Mercy
Devadass Jessy Mercy
JSJayaprakash Suresh
Jayaprakash Suresh
JJJashwanth raj J
Jashwanth raj J
KGKoyeli Girigoswami
Koyeli Girigoswami
Developing an effective vaccine that is safer is the main focus in the field of cancer immunotherapy. Among other therapeutic approaches, cancer nanovaccination is formulated to deliver tumor adjuvant or antigen to the antigen-presenting cells (APCs) to prevent cancer relapse and metastasis. It has shown excellent efficacy in inhibiting cancer growth. Herein, we discussed various forms of nanovaccines, including lipid-based nanovaccines, metal-based nanovaccines, carbon nanotube-based nanovaccines, PLGA-based nanovaccines, exosome-based nanovaccines, dendritic cell-based nanovaccines, and self-adjuvant nanovaccines in cancer immunotherapy, including their therapeutic effect. We expect that the investigated content will provide a valuable reference for future research and the development of nanovaccines for cancer treatment.